慢性肠系膜缺血的临床实践指南:血管外科学会
本指南由血管外科学会制定,针对动脉粥样硬化性慢性肠系膜缺血(CMI)的诊断与治疗提出推荐。患者出现符合CMI的症状时应尽快行CT血管造影检查,并以肠系膜上动脉为首要靶血管进行血运重建,首选球囊扩张式覆膜支架的腔内治疗。
要点
- 有CMI症状者应尽快行CT血管造影排查其他病因
- 血运重建以肠系膜上动脉为首要靶血管
- 腔内治疗(球囊扩张式覆膜支架)为初始首选,开放手术留给特定年轻及不适合腔内者
核心结论
- 指南基于现有最佳证据制定,旨在优化CMI患者的诊疗,并指出多个未来研究方向。
研究设计与样本
- 血管外科学会成立由血管外科医生及有循证综述经验人员组成的委员会,聚焦诊断评估、治疗指征、治疗选择、围术期评估、腔内/开放血运重建、监测与再干预六个领域。
- 证据团队开展正式系统综述以确定最佳血运重建技术,采用GRADE系统结合文献、数据强度与共识制定推荐。
主要发现
- 症状符合CMI者应尽快完成包括CT血管造影在内的检查,以排除其他潜在病因。
- 诊断需有肠系膜血管(尤其肠系膜上动脉)显著闭塞性病变支持。
- 治疗需血运重建,首要靶血管为肠系膜上动脉。
- 推荐以球囊扩张式覆膜支架行腔内血运重建作为初始治疗,开放修复保留给特定年轻患者及不适合腔内治疗者。
- 血运重建后及无症状的重度肠系膜闭塞病变患者均推荐长期随访与监测,再狭窄所致复发症状按新发病变以腔内优先处理。
临床怎么用
- 对疑似CMI者尽早行CT血管造影检查并评估肠系膜上动脉病变。
- 初始治疗优先选择球囊扩张式覆膜支架腔内血运重建。
- 开放手术用于特定年轻患者和腔内治疗不适合者,术后及重度无症状病变需长期监测。
局限性
- 原文未报告具体研究样本量、效应值及证据等级细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic mesenteric ischemia (CMI) results from the inability to achieve adequate postprandial intestinal blood flow, usually from atherosclerotic occlusive disease at the origins of the mesenteric vessels. Patients typically present with postprandial pain, food fear, and weight loss, although they can present with acute mesenteric ischemia and bowel infarction. The diagnosis requires a combination of the appropriate clinical symptoms and significant mesenteric artery occlusive disease, although it is often delayed given the spectrum of gastrointestinal disorders associated with abdominal pain and weight loss. The treatment goals include relieving the presenting symptoms, preventing progression to acute mesenteric ischemia, and improving overall quality of life. These practice guidelines were developed to provide the best possible evidence for the diagnosis and treatment of patients with CMI from atherosclerosis. METHODS: The Society for Vascular Surgery established a committee composed of vascular surgeons and individuals experienced with evidence-based reviews. The committee focused on six specific areas, including the diagnostic evaluation, indications for treatment, choice of treatment, perioperative evaluation, endovascular/open revascularization, and surveillance/remediation. A formal systematic review was performed by the evidence team to identify the optimal technique for revascularization. Specific practice recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation system based on review of literature, the strength of the data, and consensus. RESULTS: Patients with symptoms consistent with CMI should undergo an expedited workup, including a computed tomography arteriogram, to exclude other potential causes. The diagnosis is supported by significant arterial occlusive disease in the mesenteric vessels, particularly the superior mesenteric artery. Treatment requires revascularization with the primary target being the superior mesenteric artery. Endovascular revascularization with a balloon-expandable covered intraluminal stent is the recommended initial treatment with open repair reserved for select younger patients and those who are not endovascular candidates. Long-term follow-up and surveillance are recommended after revascularization and for asymptomatic patients with severe mesenteric occlusive disease. Patient with recurrent symptoms after revascularization owing to recurrent stenoses should be treated with an endovascular-first approach, similar to the de novo lesion. CONCLUSIONS: These practice guidelines were developed based on the best available evidence. They should help to optimize the care of patients with CMI. Multiple areas for future research were identified.
引用
- Huber TS, Björck M, Chandra A, et al. Chronic mesenteric ischemia: Clinical practice guidelines from the Society for Vascular Surgery. J Vasc Surg. 2020. PMID: 33171195. doi:10.1016/j.jvs.2020.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。